Medicare Advantage brokers could now focus more on making money and on commercials than on your healthcare
The court said an attempt to curtail payments for brokers was an overreach by the Centers for Medicare & Medicaid Services.
MarketWatch 
Bitcoin, Ethereum, XRP, Dogecoin Up As Market Awaits Nvidia Earnings
Cryptocurrency markets are trading higher ahead of Nvidia’s earnings report. read more
Benzinga 
RFK Jr. Rescinds Emergency Authorizations For COVID-19 Vaccines
FDA approves Pfizer, Moderna, and Novavax Covid vaccines for high-risk groups as emergency authorizations end and vaccines transition to full marketing. read more
Webull Q2 Earnings Preview: Can Crypto Relaunch Help Boost Shares?
Webull Corporation (NASDAQ: BULL ) aims to highlight recent wins in cryptocurrency and its evolution since going public, as the company reports second-quarter financial results on Thursday read more
Polestar Stock Is Trending Wednesday: What's Going On?
Polestar Automotive Holding UK PLC (NASDAQ: PSNY) shares are trading higher Wednesday as bullish momentum is supported by increased trading volume. Here's a look at what you need to know. read more
Assessing Oxford Industries: Insights From 6 Financial Analysts
Latest Ratings for OXM Date Firm Action From To Jan 2022 Citigroup Downgrades Neutral Sell Sep 2021 Telsey Advisory Group Maintains Market Perform Jun 2021 Citigroup Maintains Neutral View More Analyst Ratings for OXM View the Latest Analyst Ratings read more
4 Analysts Assess Kimco Realty: What You Need To Know
Latest Ratings for KIM Date Firm Action From To Jan 2022 Jefferies Upgrades Hold Buy Jan 2022 Argus Research Upgrades Hold Buy Jan 2022 Deutsche Bank Downgrades Buy Hold View More Analyst Ratings for KIM View the Latest Analyst Ratings read more
What Analysts Are Saying About Federal Realty Investment Stock
Latest Ratings for FRT Date Firm Action From To Feb 2022 Mizuho Maintains Buy Feb 2022 Capital One Upgrades Equal-Weight Overweight Jan 2022 Deutsche Bank Maintains Buy View More Analyst Ratings for FRT View the Latest Analyst Ratings read more
Delta to pay out $79 million after its jet dumped fuel over Los Angeles
The payout follows years of legal battles over a midair fuel release that doused LA homes and schools and sparked dozens of complaints
Quartz 
Ether’s summer surge may be pausing — but this analyst sees a path to $7,000 by year-end
Ether’s hot summer may be ending, but some analysts say the rally is far from over.
Taylor Swift And Travis Kelce Are Engaged—And Polymarket Trader 'Romanticpaul' Predicted It
A Polymarket trader using the handle "romanticpaul" earned more than $3,000 in profits after correctly wagering on Taylor Swift's engagement to NFL star Travis Kelce just hours before the couple confirmed the news. read more
Chinese Stocks Sink As Bubble Fears Revive Memories Of 2015 Crash
US-listed Chinese stocks drop as investors worry about similarities to 2015 bubble. Alibaba's AI efforts struggle to generate revenue. read more
Summit, Akeso Report Lung Cancer Survival Boost With Ivonescimab, A Rival To Merck's Keytruda Multi-Billion Dollar Franchise, Says Analyst
Summit and Akeso report ivonescimab's survival benefit in lung cancer, boosting approval odds and positioning it as a Keytruda challenger. Latest Ratings for SMMT Date Firm Action From To Nov 2020 HC Wainwright & Co. Downgrades Buy Neutral Mar 2020 HC Wainwright & Co. Initiates Coverage On Buy Jun 2018 Janney Montgomery Scott Downgrades Buy Neutral View More Analyst Ratings for SMMT View the Latest Analyst Ratings read more